Sodium zirconium cyclosilicate was approved for medical use in the European Union and in the United States in 2018.[1][3][4] It was developed by AstraZeneca.[1] In the United States it costs about $US24 per dose.[5] In the United Kingdom as of 2019 it costs the NHS about £7.12 per dose.[6]